Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis
Public ClinicalTrials.gov record NCT00667160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Pediatric Patients With Mild Atopic Dermatitis
Study identification
- NCT ID
- NCT00667160
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Enrollment
- 426 participants
Conditions and interventions
Conditions
Interventions
- tacrolimus ointment Drug
- pimecrolimus cream Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2002
- Primary completion
- Oct 31, 2003
- Completion
- Oct 31, 2003
- Last update posted
- Sep 17, 2014
2002 – 2003
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | San Diego | California | 92123 | — |
| Not listed | New Haven | Connecticut | 06519 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Miami | Florida | 33155 | — |
| Not listed | Chicago | Illinois | 60614 | — |
| Not listed | Boston | Massachusetts | 02115 | — |
| Not listed | Clinton Township | Michigan | 48308 | — |
| Not listed | Fridley | Minnesota | 55432 | — |
| Not listed | Omaha | Nebraska | 68144 | — |
| Not listed | Reno | Nevada | 89511 | — |
| Not listed | Durham | North Carolina | 27705 | — |
| Not listed | Wilmington | North Carolina | 28401 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Portland | Oregon | 97201 | — |
| Not listed | Pittsburgh | Pennsylvania | 15218 | — |
| Not listed | Dallas | Texas | 75390 | — |
| Not listed | Galveston | Texas | 77555 | — |
| Not listed | Houston | Texas | 62016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00667160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 17, 2014 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00667160 live on ClinicalTrials.gov.